Development and clinical assessment of new objective adherence markers for four microbicide delivery systems used in HIV prevention studies
Abstract Background Adherence is critical for successful topical, vaginally delivered anti-retroviral (ARV)-based HIV pre-exposure prophylaxis (PrEP). Quantitating systemic or tissue ARV levels through LC–MS/MS is currently viewed as the most reliable measure of adherence. However, for placebo-contr...
Main Authors: | Terry A. Jacot, Meredith R. Clark, Oluwatosin E. Adedipe, Susan Godbout, Abby G. Peele, Susan Ju, Jill L. Schwartz, Andrea R. Thurman, Gustavo F. Doncel |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2018-11-01
|
Series: | Clinical and Translational Medicine |
Subjects: | |
Online Access: | http://link.springer.com/article/10.1186/s40169-018-0213-6 |
Similar Items
-
Application of a composite measure of product adherence, protocol compliance, and semen exposure to a phase III microbicide HIV prevention trial
by: Terry A. Jacot, et al.
Published: (2021-09-01) -
Rational design of HIV vaccines and microbicides: report of the EUROPRISE annual conference 2011
by: Ruffin Nicolas, et al.
Published: (2012-07-01) -
Update on microbicide research and development-seeking new HIV prevention tools for women
by: Mertenskoetter T, et al.
Published: (2011-01-01) -
Understanding women’s motivations to participate in MTN-003/VOICE, a phase 2b HIV prevention trial with low adherence
by: Ariana W. K. Katz, et al.
Published: (2019-01-01) -
Changing the PrEP Narrative: A Call to Action to Increase PrEP Uptake among Women
by: Alina Cernasev, et al.
Published: (2021-06-01)